Chapman Christopher C Jr - Net Worth and Insider Trading

Chapman Christopher C Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chapman Christopher C Jr owns 2 companies in total, including MyMD Pharmaceuticals Inc (MYMD) , and Mira Pharmaceuticals Inc (MIRA) .

Click here to see the complete history of Chapman Christopher C Jr’s form 4 insider trades.

Insider Ownership Summary of Chapman Christopher C Jr

Ticker	Comapny	Transaction Date	Type of Owner
MYMD	MyMD Pharmaceuticals Inc	2021-04-16	director & President & Chief Med. Officer
MIRA	Mira Pharmaceuticals Inc	2023-08-02	director & Executive Chairman

Chapman Christopher C Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chapman Christopher C Jr Ownership Network

Ownership Network List of Chapman Christopher C Jr

No Data

Ownership Network Relation of Chapman Christopher C Jr

Chapman Christopher C Jr Owned Company Details

What does MyMD Pharmaceuticals Inc do?

Who are the key executives at MyMD Pharmaceuticals Inc?

Chapman Christopher C Jr is the director & President & Chief Med. Officer of MyMD Pharmaceuticals Inc. Other key executives at MyMD Pharmaceuticals Inc include EVP of Operations & GC Paul Rivard , Chief Scientific Officer Adam Kaplin , and 10 percent owner Caroline C Williams .

MyMD Pharmaceuticals Inc (MYMD) Insider Trades Summary

Over the past 18 months, Chapman Christopher C Jr made no insider transaction in MyMD Pharmaceuticals Inc (MYMD). Other recent insider transactions involving MyMD Pharmaceuticals Inc (MYMD) include a net purchase of 185,000 shares made by Paul Rivard ,

In summary, during the past 3 months, insiders sold 0 shares of MyMD Pharmaceuticals Inc (MYMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyMD Pharmaceuticals Inc (MYMD) were sold and 6,167 shares were bought by its insiders, resulting in a net purchase of 6,167 shares.

MyMD Pharmaceuticals Inc (MYMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

MyMD Pharmaceuticals Inc Insider Transactions

No Available Data

Chapman Christopher C Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Chapman Christopher C Jr. You might contact Chapman Christopher C Jr via mailing address: C/o Star Scientific, Inc., 7475 Wisconsin Avenue, Suite 850, Bethesda Md 20814.

Discussions on Chapman Christopher C Jr

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.